Marc Ventayol-Guirado

Mr. Marc Ventayol-Guirado

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 August 2024 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
MVMarc Ventayol-Guirado
Marc Ventayol-Guirado
LTLaura Torres
Laura Torres
VAVictor Asensio‐Landa
Victor Asensio‐Landa
ÁPÁngeles Pérez‐Granero
Ángeles Pérez‐Granero
MMMaria Isabel Madrid
Maria Isabel Madrid
FSFernando Santos‐Simarro
Fernando Santos‐Simarro

22 May 2025 in Journal of Assisted Reproduction and Genetics
Verified
Journal Article
Closed access
PDF file
MVMarc Ventayol-Guirado
Marc Ventayol-Guirado
JHJessica Hernandez-Rodriguez
Jessica Hernandez-Rodriguez
JFJoana Florit
Joana Florit
MLMaria Victoria Llull-Alberti
Maria Victoria Llull-Alberti
RBRaquel Barragan
Raquel Barragan
LPLaura Peralta
Laura Peralta

Verified
Journal Article
Open access
PDF file
EAEmilia Amengual-Cladera
Emilia Amengual-Cladera
MLMARIA VICTORIA LLULL
MARIA VICTORIA LLULL
MVMarc Ventayol-Guirado
Marc Ventayol-Guirado
JBJuan Antonio Jiménez Barceló
Juan Antonio Jiménez Barceló
JRJairo Rocha
Jairo Rocha
DSDamian Heine Suñer
Damian Heine Suñer
Congenital heart defects (CHDs) occur in 50–75% of patients with 22q11.2 deletion syndrome (22q11.2DS), ranging from mild to severe manifestations. The genetic and environmental factors contributing to variable CHD phenotypes in 22q11.2DS are largely unknown. In this study, we used a mouse model of 22q11.2DS, termed Df1/+, to evaluate the effect of maternal vitamin A (VitA) dietary imbalance (supplementation or deficiency) on the incidence of aortic arch defects (AADs), which is a common type of CHD observed in both 22q11.2DS patients and Df1/+ mouse embryos. While most groups showed a previously observed 30% AAD incidence, two groups exhibited significantly higher rates: (1) Df1/+ embryos from WT mothers on a VitA-Supl diet (51% AADs) and (2) Df1/+ embryos from Df1/+ mothers on a VitA-Def diet (45% AADs). Thus, a low or high maternal VitA diet can increase the frequency of AADs in embryos depending on the maternal genotype. Transcriptomic analysis of the hearts of these high-risk embryos at embryonic day (E)18.5 revealed downregulation of key genes (Hdac3, Ptgds, Sirt5, Pfkm, and Lclat1) associated with energy metabolism pathways, such as oxidative phosphorylation and glycolysis, suggesting impaired cardiac recovery mechanisms. In conclusion, our findings demonstrate that altered VitA exposure can exacerbate AAD incidence in a maternal-genotype-dependent manner, highlighting the complex interplay between embryonic and maternal genetic background and environmental factors in CHDs associated with 22q11.2DS.